DWORAK LEIDEN enters TSCAN THERAPEUTICS, INC. with 5.69K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/24/2023ACC: 0000950170-23-034147
Officer· Chief Accounting Officer
Since Jul 2023
5.69K
Baseline shares
100% direct
5.69K
Direct ownership
1 position
230.05K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Voting Common Stock
DirectShares owned5.69K
Total
5.69K direct5.69K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Voting Common Stock | 5.69K | Direct |
| Total | 5.69K | 5.69K direct |
Derivative Holdings3
Stock Option (Right to Buy)
DirectUnderlying security
Voting Common Stock
Underlying shares
28.75K
Shares owned
N/A
Exercise price
1.81
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Voting Common Stock
Underlying shares
163.80K
Shares owned
N/A
Exercise price
2.49
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Voting Common Stock
Underlying shares
37.50K
Shares owned
N/A
Exercise price
2.90
Expiration
—
Exercise window
—
Total
Underlying
230.05K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Voting Common Stock | 1.81 | — | — | 28.75K | N/A |
| Stock Option (Right to Buy) Direct | Voting Common Stock | 2.49 | — | — | 163.80K | N/A |
| Stock Option (Right to Buy) Direct | Voting Common Stock | 2.90 | — | — | 37.50K | N/A |
| Total | 230.05K | 0.00 | ||||